Nov 08, 2018
By BioPharm International Editors
Formulation issues cause significant drug project delays and project failures, according to a 2018 survey conducted by Informa Pharma Intelligence, Rentschler Biopharma, and LEUKOCARE.
Nov 01, 2018
BioPharm International
As biologic drugs grow increasingly complex, drug delivery mechanisms such as prefilled syringes are being adapted to meet the challenges.
Oct 23, 2018
Sponsored Content
Orally disintegrating tablets (ODTs), also known as orodispersible tablets, are unique dosage forms formulated to improve their in vivo disintegration and dissolution rates. It is a big challenge to ODT producers to achieve a minimum disintegration time while keeping formulation simple and robust. The required advances in pharmaceutical manufacturing occurred when excipient suppliers developed multi-functional types for direct compression. Roquette’s PEARLITOL® Flash, a combination of mannitol and starch, is a ready-to-use excipient for orodispersible tablets. This article describes its application to formulation and how this delivers advantages like robustness and rapid disintegration time. PEARLITOL® Flash means problem-free ODT formulation.
Oct 01, 2018
BioPharm International
Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.
Sep 19, 2018
By BioPharm International Editors
The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.
Sep 07, 2018
By BioPharm International Editors
Becton Dickinson’s (BD) Advanced Bioprocessing business will be integrated into Thermo Fisher's Life Sciences Solutions segment.
Sep 01, 2018
BioPharm International
The development and optimization of an efficient conjugation process involves identifying the critical quality attributes and monitoring critical process parameters.
Aug 01, 2018
BioPharm International
Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.
Jun 26, 2018
By BioPharm International Editors
A new oral delivery method developed by the Harvard John A. Paulson School of Engineering and Applied Sciences could change the way diabetics regulate blood sugar levels.
Jun 15, 2018
BioPharm International
Single-use technologies have become increasingly prevalent in final fill/finish operations for biologics.
lorem ipsum